Scholarly Index
Elisabeth Tournier‐Lasserve
Inserm; 25,308 total citations; 303 total publications; best world rank #18
Inserm
25,308Total citations
303Total publications
83H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Moyamoya disease diagnosis and treatment | Lifetime | 19 | FR 2 | 99.21 |
| Cerebrovascular and genetic disorders | Lifetime | 18 | FR 1 | 98.85 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 133 | FR 8 | 98.88 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 128 | FR 7 | 98.86 |
| Intracranial Aneurysms: Treatment and Complications | Lifetime | 403 | FR 26 | 98.13 |
| Cell Adhesion Molecules Research | Lifetime | 998 | FR 25 | 97.29 |
| Genetic Neurodegenerative Diseases | Lifetime | 743 | FR 53 | 96.22 |
| Migraine and Headache Studies | Lifetime | 475 | FR 9 | 95.02 |
| Neurological diseases and metabolism | Lifetime | 497 | FR 27 | 94.48 |
| Metalloenzymes and iron-sulfur proteins | Lifetime | 784 | FR 66 | 89.69 |
| Cerebrovascular and genetic disorders | 2021-2025 | 35 | FR 6 | 90.47 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 117 | FR 4 | 88.16 |
| Cell Adhesion Molecules Research | 2021-2025 | 653 | FR 23 | 73.48 |
| Neurological Complications and Syndromes | 2021-2025 | 682 | FR 42 | 56.54 |